Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shankar Siva

Showing results (11-20 of 349) with videos related to

Pageof 35
Sort By:
European Urology|August 2, 2021
Everything But the Kitchen Sink: Comprehensive Nodal Irradiation with Androgen Deprivation in OLIGOPELVISPiet Ost, Shankar Siva, Thomas Zilli
The Lancet. Oncology|May 31, 2024
Stereotactic ablative radiotherapy for primary kidney cancer - Authors' replyShankar Siva, Daniel Moon, David Pryor
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2010
Stereotactic radiotherapy for pulmonary oligometastases: a systematic reviewShankar Siva, Michael MacManus, David Ball
BJU International|January 30, 2023
Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: combination of stereotactic ablative body radiotherapy and radical nephrectomy for synchronous bilateral primary renal cell carcinomaMuhammad Ali, Mathieu Gaudreault, Shankar Siva
European Urology|April 28, 2024
OLIGOPELVIS and the "All You Can Eat" Strategy for Oligorecurrent Nodal Prostate Cancer: Are We Already Full?Piet Ost, Shankar Siva, Thomas Zilli
Advances in Radiation Oncology|July 5, 2022
SABR for Synchronous Bilateral Primary Renal Cell Carcinoma: A Case ReportMuhammad Ali, Mathieu Gaudreault, Shankar Siva
European Urology|June 2, 2023
Re: Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate CancerDavid Chang, Sree Appu, Shankar Siva
International Journal of Radiation Oncology, Biology, Physics|April 18, 2026
"Can We Wait a Little Longer?" The Emerging Role of SABR in Deferring Systemic Therapy for Oligometastatic Renal Cell CarcinomaEdward Chmiel, Felipe Couñago, Shankar Siva
The Lancet. Oncology|March 13, 2022
Pre-emptive or reactive? PROMPT spinal screening in metastatic castration-resistant prostate cancerShankar Siva, Muhammad Ali, Mathias Guckenberger
JAMA Oncology|January 12, 2023
The MIRAGE Trial-Optical Illusion or the Future of Prostate Stereotactic Radiotherapy?Shankar Siva, Piet Ost, Muhammad Ali
Pageof 35

Showing results (11-20 of 349) with videos related to

Sort By:
Pageof 35
European Urology|August 2, 2021
Everything But the Kitchen Sink: Comprehensive Nodal Irradiation with Androgen Deprivation in OLIGOPELVISPiet Ost, Shankar Siva, Thomas Zilli
The Lancet. Oncology|May 31, 2024
Stereotactic ablative radiotherapy for primary kidney cancer - Authors' replyShankar Siva, Daniel Moon, David Pryor
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2010
Stereotactic radiotherapy for pulmonary oligometastases: a systematic reviewShankar Siva, Michael MacManus, David Ball
BJU International|January 30, 2023
Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: combination of stereotactic ablative body radiotherapy and radical nephrectomy for synchronous bilateral primary renal cell carcinomaMuhammad Ali, Mathieu Gaudreault, Shankar Siva
European Urology|April 28, 2024
OLIGOPELVIS and the "All You Can Eat" Strategy for Oligorecurrent Nodal Prostate Cancer: Are We Already Full?Piet Ost, Shankar Siva, Thomas Zilli
Advances in Radiation Oncology|July 5, 2022
SABR for Synchronous Bilateral Primary Renal Cell Carcinoma: A Case ReportMuhammad Ali, Mathieu Gaudreault, Shankar Siva
European Urology|June 2, 2023
Re: Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate CancerDavid Chang, Sree Appu, Shankar Siva
International Journal of Radiation Oncology, Biology, Physics|April 18, 2026
"Can We Wait a Little Longer?" The Emerging Role of SABR in Deferring Systemic Therapy for Oligometastatic Renal Cell CarcinomaEdward Chmiel, Felipe Couñago, Shankar Siva
The Lancet. Oncology|March 13, 2022
Pre-emptive or reactive? PROMPT spinal screening in metastatic castration-resistant prostate cancerShankar Siva, Muhammad Ali, Mathias Guckenberger
JAMA Oncology|January 12, 2023
The MIRAGE Trial-Optical Illusion or the Future of Prostate Stereotactic Radiotherapy?Shankar Siva, Piet Ost, Muhammad Ali
Pageof 35